Federal University of Pará (UFPA), Biological Sciences Institute, Virology Laboratory, Belem, PA, Brazil.
Federal University of Pará (UFPA), Institute of Health Sciences, School of Medicine, Belem, PA, Brazil; João de Barros Barreto University Hospital, Belem, PA, Brazil.
Braz J Infect Dis. 2020 Jul-Aug;24(4):304-309. doi: 10.1016/j.bjid.2020.06.010. Epub 2020 Jul 28.
Despite the emergence of more effective therapies, hepatitis C virus (HCV) infection remains a serious public health problem at the global level. Currently, this virus is classified into seven genotypes and 67 subgenotypes, which in turn are distributed heterogeneously in Brazil and worldwide. Studies have shown that this genetic divergence results in differences in the progression of chronic disease associated with HCV infection and its treatment.
The aim of this study was to report the frequency of HCV genotypes in the state of Pará, Northern Brazil, and to assess the association between genotype and different clinical and laboratory characteristics, as well as risk factors for infection.
Data from 85 medical records of untreated patients who had chronic hepatitis C infection were analyzed; the patients were evaluated at two hospitals in Belem, Pará, Brazil.
Circulation of genotypes 1 and 3 was detected, with a higher prevalence of genotype 1 (75.3%) than genotype 3 (24.7%). In addition, there was a predominance of subgenotype 1b (60.34%) compared to 1a (20.69%) and 3a (18.97%). Reuse of needles and/or glass syringes was significantly associated with infection by HCV genotype 1 than genotype 3; however, the small number of patients infected with genotype 3 may have biased the results. No associations between genotype and the evaluated clinical and laboratory characteristics were observed.
This study reinforces the differences in the distribution of HCV genotypes in Brazil and showed no association between HCV genotype and progression of chronic hepatitis C in the studied group.
尽管出现了更有效的疗法,丙型肝炎病毒 (HCV) 感染仍然是全球范围内一个严重的公共卫生问题。目前,该病毒分为 7 个基因型和 67 个亚型,这些亚型在巴西和全球的分布存在异质性。研究表明,这种遗传差异导致与 HCV 感染及其治疗相关的慢性疾病进展存在差异。
本研究旨在报告巴西北部帕拉州 HCV 基因型的频率,并评估基因型与不同临床和实验室特征以及感染危险因素之间的关系。
分析了来自巴西贝伦市两家医院的 85 名未经治疗的慢性丙型肝炎感染患者的病历数据。
检测到基因型 1 和 3 的流行,基因型 1 的流行率(75.3%)高于基因型 3(24.7%)。此外,1b 亚型(60.34%)的流行率高于 1a(20.69%)和 3a(18.97%)。重复使用针具和/或玻璃注射器与 HCV 基因型 1 感染显著相关,而感染基因型 3 的患者数量较少可能会影响结果。未观察到基因型与评估的临床和实验室特征之间存在关联。
本研究加强了巴西 HCV 基因型分布的差异,并表明在研究组中,HCV 基因型与慢性丙型肝炎的进展之间没有关联。